There are over 16 million millionaires in the world today1, and at least 10% of them would eagerly try anything that might radically prolong their lifespan and improve their standard of living. However, no matter how much one is willing to pay, you are still prohibited from buying services that have not been approved by regulators, are inaccessible due to legislative inadequacies, or which require additional research.
We provide a solution to this problem by creating To launch our platform, we are raising funds a platform where individuals can devise products through a Token Sale, starting on March 22th. and services necessary for their well-being, where Funds from the Token Sale will be used to: research groups can analyze potential demand for their latest developments, and finally, where customers of our unique product can create smart contracts that will ensure autonomous purchasing of future services.
Our platform is ideally suited for deferred operations algorithmize procedures, connectome after cryopreservation or chemical fixation, and many other equally fantastic, but feasible, services, once they become legal, ethical, and available on the market.
We have gathered a team of experts in many different fields: in trust fund establishment (trust is a legal agreement that guarantees the use of funds solely for the purposes set-out by the settlor - the creator of the trust), in asset management (to ensure the trust funds of our clients will gain value until the required products and services become available), in biomedicine (to constantly monitor the compliance of our medical contractors with the standards of biomaterial storage to ensure the fulfilment of our clients’ goals) and in blockchain technology.
Following the token offering, we plan to enter the market with a service that will sustain demand by appealing to human nature. In view of the unique set of services we offer, we project to capture 10% of our target audience, with an overall market potential of 1.6 million people.